Friday, May 29, 2020 11:23:45 PM
“... this run I think was predicated on the expectation of datalock this week and I don't think it was all pump and dump ...”
But wasn’t pump and dump exactly what it was? For years now, the pattern: The company announces or hints at an anticipated milestone every few months. They seem to have a sense of exactly how many weeks or months our patience will keep us hooked on the line. A week or two before the expected milestone, the price rises with the excitement. The deadline passes, and the price crashes, often lower than before. Everyone reviews the wording the company used to telegraph the milestone, and we realize it was almost all in our own heads. They’ve used very careful language to cover their own buttocks, and in reality they promised nothing. And then there is an SEC filing indicating a financing deal occurred. We realize that during the run up not only were a high volume of investors buying, but also a high volume were selling — at a profit over the financing terms.
Right?
But wasn’t pump and dump exactly what it was? For years now, the pattern: The company announces or hints at an anticipated milestone every few months. They seem to have a sense of exactly how many weeks or months our patience will keep us hooked on the line. A week or two before the expected milestone, the price rises with the excitement. The deadline passes, and the price crashes, often lower than before. Everyone reviews the wording the company used to telegraph the milestone, and we realize it was almost all in our own heads. They’ve used very careful language to cover their own buttocks, and in reality they promised nothing. And then there is an SEC filing indicating a financing deal occurred. We realize that during the run up not only were a high volume of investors buying, but also a high volume were selling — at a profit over the financing terms.
Right?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
